Strontium chloride
Strontium chloride structure
|
Common Name | Strontium chloride | ||
|---|---|---|---|---|
| CAS Number | 10476-85-4 | Molecular Weight | 158.526 | |
| Density | 3 g/mL at 25ºC(lit.) | Boiling Point | 1250ºC | |
| Molecular Formula | Cl2Sr | Melting Point | 873ºC | |
| MSDS | Chinese USA | Flash Point | 1250°C | |
| Symbol |
GHS05 |
Signal Word | Danger | |
|
Novel Protamine-Based Polyelectrolyte Carrier Enhances Low-Dose rhBMP-2 in Posterolateral Spinal Fusion.
Spine 40 , 613-21, (2015) A rodent posterolateral spinal fusion model.This study evaluated a protamine-based polyelectrolyte complex (PEC) developed to use heparin in enhancing the biological activity of low-dose recombinant human bone morphogenetic protein-2 (rhBMP-2) in spinal fusio... |
|
|
Strontium chloride Sr 89 for treating pain from metastatic bone disease.
Am. J. Health Syst. Pharm. 52(20) , 2189-95, (1995) The role of strontium chloride Sr 89 in the palliative treatment of pain associated with metastatic bone disease is reviewed. Conventional therapies to relieve metastatic bone pain include nonopioid and opioid analgesics, hormonal therapy, external-beam irrad... |
|
|
[A case of lung cancer pain relief and safe return home by strontium chloride].
Gan To Kagaku Ryoho. 40(4) , 533-5, (2013) Strontium chloride 89 (89Sr) is used as a systemic radiopharmaceutical therapy for the palliation of pain in patients with metastatic bone cancer. A 64-year-old man had previously undergone an operation to resect his right upper lobe of lung and sixth rib. He... |
|
|
[Effects of strontium chloride activation on the cleavage rate and somatic cell nuclear transfer embryos in mice].
Zhonghua Nan Ke Xue 18(10) , 909-14, (2012) To establish a suitable protocol for activating mouse somatic cell nuclear transfer embryos with strontium chloride (SrCl2).We constructed and identified mouse nuclear transfer (NT) embryos. After nuclear injection, we activated the NT embryos using the follo... |
|
|
[Bone metastases treated with radiopharmaceuticals].
Bull. Cancer 100(11) , 1223-7, (2013) The administration of a radionuclide in unsealed source whose radiation will destroy cells that have selectively accumulated product is called radiometabolic therapy. The management of bone pain is a major problem, particularly in cases of breast or prostate ... |
|
|
A variable DNA recognition site organization establishes the LiaR-mediated cell envelope stress response of enterococci to daptomycin.
Nucleic Acids Res. , (2015) LiaR is a 'master regulator' of the cell envelope stress response in enterococci and many other Gram-positive organisms. Mutations to liaR can lead to antibiotic resistance to a variety of antibiotics including the cyclic lipopeptide daptomycin. LiaR is phosp... |
|
|
The effect of strontium and combinations of strontium and fluoride on the remineralization of artificial caries lesions in vitro.
Quintessence Int. 43(7) , e95-103, (2012) To determine the effect of relatively low strontium concentrations on enamel remineralization and investigate the dose-response effects of strontium and fluoride combinations on the remineralization of artificial caries lesions in vitro.Artificial caries lesi... |
|
|
[Encounter of cancer cells with bone. Treatment of bone metastases from breast cancer].
Clin. Calcium 21(3) , 429-38, (2011) In metastatic breast cancer the most common metastatic site is bone. Skeletal-related events (SREs) as well as bone pain are well-known characteristics of bone metastasis. Activation of osteoclast is the most important mechanism for the progression of bone me... |
|
|
Strontium enhances osteogenic differentiation of mesenchymal stem cells and in vivo bone formation by activating Wnt/catenin signaling.
Stem Cells 29(6) , 981-91, (2011) Strontium ranelate is a newly approved drug that can reduce the risk of vertebral fracture, which is attributed to its dual function in increasing the bone formation and decreasing the bone resorption. Strontium-containing hydroxyapatite was also demonstrated... |
|
|
Use of radionuclides in metastatic prostate cancer: pain relief and beyond.
Curr. Opin. Support. Palliat. Care 6(3) , 310-5, (2012) Bone metastases in prostate cancer are often the cause of significant morbidity in patients with castrate-resistant disease, and several studies have shown significant pain palliation with systemic radionuclide treatment. The purpose of this review is to disc... |